The survival data reported in Figure 2 are consistent with radiation generating an increased immunosuppressive tumor microenvironment that promotes therapeutic resistance and loss of sensitivity to PD-L1 therapy in aggressive recurrent mouse gliomas. The gene discussed is CD274; the disease is neoplasm.